Science for All — Affordable, Accessible, Advanced.
AI-Driven Solutions for Next-Gen Therapeutics.
AI-powered bulk RNA-seq analysis, pathway prioritization, transcription-factor activity, and biological interpretation.
Developed, operated, and supported by Vaxonyx USA, a separate U.S.-based biotechnology company with shared founding leadership.
Vaxogene advances biotechnology research, scientific collaboration, and translational innovation from India. We apply genomics, bioinformatics, molecular biology, and AI-guided approaches to support the development of next-generation therapeutics for global health challenges.
Integrated capabilities supporting biological discovery, scientific collaboration, and translational development.
Computational approaches for transcriptomics, metagenomics, genomic variation, immune genetics, biomarker research, and biological interpretation.
Explore platformsMolecular biology, biochemical assays, virology-based research, experimental planning, and analytical support for biotechnology programs.
Explore servicesCollaborative research supporting vaccines, therapeutic targets, regenerative medicine, preclinical development, and precision biotechnology.
View innovationFrom biological discovery to translational strategy, Vaxogene brings together genomics, molecular biology, scientific services, and collaborative research.
Tell us about your scientific question, research model, technology requirements, and translational goals. We can help identify a practical route forward.
Discuss a Project